New Oncology Drugs in 2017
Originally presented at HOPA's 14th Annual Conference, March 2018.
This session will review all medications approved by the U.S. Food and Drug Administration for oncologic indications in 2017. The discussion of each medication will include its pharmacology, evidence to support its approval, its place in therapy, and significant adverse effects.
Amy Seung, PharmD BCOP
Patient Management & Therapeutics
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by March 22, 2021.
This activity has been approved for .125 CEU
This course is also included as part of the Best of 2018 Annual Conference Recordings Bundle.
Release Date: September 26, 2018
Expiration Date: March 22, 2021